Invest in the weight loss drug revolution and beyond
$HRTS ETF
Learn more
bloomberg
cnbc
financial-times
reuters
wsj

What differentiates Tema?

Process

Process

Bottom-up
fundamental
research-led
investment process

people-certified-icon

People

Experienced team
with sector
expertise

Icon-innovation-2

Product

Compelling
innovative
exposures

icons-themes-what-precision

Positioning

Precise and
defined underlying
exposures

The Next 10 Weight-Loss Drugs: Life After Ozempic

The Next 10 Weight-Loss Drugs: Life After Ozempic

By David K. Song, MD, PhD, CFA

How to position a portfolio for the US election

How to position a portfolio for the US election

By Yuri Khodjamirian, CFA

Latest Webinar

How to Invest in the Weight Loss Drug Revolution

Maurits Pot
CEO

May 15th 13:00 PM ET

Chief Investment Officer
Yuri Khodjamirian, CFA

Yuri spent over a decade at Majedie Asset Management managing UK and Global portfolios. As co-manager of the Majedie UK Income Fund, he helped build the fund from start-up stage, raising several billion in assets. He later set up his own long-only fund and sits on the board of a private Scandinavian biotechnology company. He holds degrees in Economics from University of Cambridge and LSE (distinction), as well as a degree in Bioscience Enterprise from University of Cambridge. Yuri is a CFA charter holder.

Investment Partner
David K. Song, MD, PhD, CFA

David Song, Investment Partner, has led biotechnology and healthcare investment teams throughout his extensive 25-year career at Rockefeller Capital Management, Millennium and Balyasny. He studied Economics and Biochemistry at Yale, is a medical doctor and has a PhD in Applied Economics from Wharton.

Investment Partner
Chris Semenuk

Chris is a global fund manager with more than 25 years of experience, 20 of which was spent managing a $5bn global equities fund at TIAA, a leading US based financial services company. Chris managed the fund since inception and raised several billion dollars in assets. Chris has a Bachelor's Degree in Economics from Union College in New York State.

Investment Partner
Javier G. Lastra, CFA

Javier is a consumer sector expert with over 23 years of investment research experience. He is the former head of beverage sector equity research at Berenberg and Exane. He is also the former head of consumer staples research at Goldman Sachs. Javier holds a BA from CUNEF Business School, an Executive Program from Kellogg School of Management, and is a CFA charter holder.

Tema

Tema’s mission is to empower investors with unexplored and innovative solutions

Exchange-Traded Funds (ETFs)

Exchange-Traded Funds (ETFs)

A lineup that spans life sciences, core equity, and thematics.

ETF Model Portfolios

ETF Model
Portfolios

Differentiated, primarily open architecture solutions for the financial advisor needs of tomorrow.

Institutional Solutions

Institutional
Solutions

Whether via separately managed accounts (SMAs), private funds, or other custom services, we have an experienced team ready to offer support.